Vimarsana
Biggest News Aggregation in the World

Value Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Value Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Value Pathway Today - Breaking & Trending Today

ACR applauds telehealth flexibility, coding changes to proposed 2022 Physician Fee Schedule - Vimarsana News

ACR applauds telehealth flexibility, coding changes to proposed 2022 Physician Fee Schedule

The American College of Rheumatology praised several aspects of a 2022 Medicare physician fee schedule proposed rule, including evaluation and management coding changes and the promise of greater telehealth flexibility. The ACR issued its statement days after submitting formal comments to CMS regarding the proposed rule. According to the group, rheumatology leaders are “encouraged” by

Source: healio.com
Alston & Bird Health Care Week in Review - December 2020 #3 | Alston & Bird - Vimarsana News

Alston & Bird Health Care Week in Review - December 2020 #3 | Alston & Bird

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: On Wednesday, HHS finalized its review of Phase 3 Provider Relief Fund applications and began distribution of the funds. Read more about this action and other news below. I. Regulations, Notices & Guidance On December 14, 2020, the Department of Health and Human Services (HHS), along with s...

Alston & Bird Health Care Week in Review - December 2020 #2 | Alston & Bird - Vimarsana News

Alston & Bird Health Care Week in Review - December 2020 #2 | Alston & Bird

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, HHS issued a final rule intended to govern the administrative dispute process in the 340B Drug Pricing Program. Read more about the rule and other news below. I. Regulations, Notices & Guidance On December 8, 2020, the Food & Drug Administration (FDA) issued guidance entitled, Be...